NCT06755619View on ClinicalTrials.gov

CtDNA for Early Response Assessment in PCNSL Treated with 1st Line Curative Intent (NLG-PCNSL-01)

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2038

Conditions
Primary Central Nervous System (CNS) Lymphoma
Trial Locations (5)

Unknown

NOT_YET_RECRUITING

Helsinki University Hospital, Helsinki

NOT_YET_RECRUITING

Kuopio University Hospital, Kuopio

NOT_YET_RECRUITING

Oulu University Hospital, Oulu

RECRUITING

Tampere University Hospital, Tampere

NOT_YET_RECRUITING

Turku University Hospital, Turku

All Listed Sponsors
lead

Nordic Lymphoma Group

NETWORK